Insider Shareholders with Direct Ownership of Amylyx Pharmaceuticals, Inc. (AMLX)
This section provides a comprehensive overview of the insiders with direct ownership of Amylyx Pharmaceuticals, Inc. (AMLX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Amylyx Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Invest 1 B.V. Als
> 10% Shareholder |
5,955,889 | 60,609 | 5,895,280 $24 Million | 2 |
Jul 06, 2022
Reduced 0.04%
|
|
Morningside Venture Investments Ltd
> 10% Shareholder |
10,678,808 | 2,683,296 | 4,997,302 $20.3 Million | 12 |
Aug 15, 2023
Reduced 28.58%
|
|
Joshua B Cohen
Co-Chief Executive Officer |
876,875 | 128,565 | 3,220,569 $13.1 Million | 13 |
Sep 30, 2024
Reduced 0.57%
|
|
Justin B. Klee
Co-Chief Executive Officer |
840,565 | 128,565 | 3,184,259 $13 Million | 11 |
Nov 04, 2024
Added 1.96%
|
| 126,315 | 138,450 | 858,571 $3.49 Million | 5 |
Sep 03, 2024
Added 10.43%
|
|
|
Margaret Olinger
Chief Commercial Officer |
100,911 | 1,580 | 276,108 $1.12 Million | 6 |
Dec 27, 2023
Added 8.3%
|
|
James M Frates
Chief Financial Officer |
282,837 | 69,508 | 233,464 $950,198 | 13 |
Sep 12, 2024
Added 14.63%
|
|
Patrick D Yeramian
Chief Medical Officer |
101,078 | 118,983 | 205,605 $836,812 | 9 |
Jan 09, 2024
Reduced 1.35%
|
|
Gina Mazzariello
Chief Legal Officer |
176,560 | 33,792 | 142,768 $581,065 | 11 |
Sep 30, 2024
Reduced 5.75%
|
|
Camille L Bedrosian
Chief Medical Officer |
155,243 | 16,863 | 138,380 $563,206 | 4 |
Dec 02, 2024
Reduced 3.77%
|
| 55,000 | 0 | 55,000 $223,850 | 3 |
Sep 05, 2024
Added 47.62%
|
|
|
Isaac Cheng
Director |
6,578 | 0 | 6,578 $26,772 | 1 |
Jan 06, 2022
Added 50.0%
|
| 5,000 | 0 | 5,000 $20,350 | 2 |
May 15, 2024
Added 31.03%
|
|
| 3,947 | 0 | 3,947 $16,064 | 1 |
Jan 06, 2022
Added 50.0%
|